Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
NCT05430035
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Gallbladder Adenocarcinoma
Interventions
DRUG:
HIPEC
Sponsor
West Virginia University